Optimizing patient outcomes in interstitial lung disease through pre- and post-transplant management strategies

doi:10.5500/wjt.v15.i3.101866

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (394)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

218

Figures (1-1)

Tables (1-1)

Sum=313

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=56

Sep 18, 2025 (publication date) through Apr 30, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Transplant. Sep 18, 2025; 15(3): 101866
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101866

Optimizing patient outcomes in interstitial lung disease through pre- and post-transplant management strategies

Vasiliki E Georgakopoulou

Vasiliki E Georgakopoulou, Department of Pathophysiology, Laiko General Hospital, Medical School of National and Kapodistrian University of Athens, Athens 11527, Greece

Author contributions: Georgakopoulou VE designed the research study, performed the research, analyzed the data and wrote the manuscript.

Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Vasiliki E Georgakopoulou, MD, Doctor, Department of Pathophysiology, Laiko General Hospital, Medical School of National and Kapodistrian University of Athens, 17 Agiou Toma Street, Athens 11527, Greece. vaso_georgakopoulou@hotmail.com

Received: September 28, 2024
Revised: February 10, 2025
Accepted: February 27, 2025
Published online: September 18, 2025
Processing time: 201 Days and 10.6 Hours

Core Tip

Core Tip: This review highlights the complexities of managing advanced interstitial lung diseases in the context of lung transplantation. Comprehensive pre-transplant evaluation and meticulous post-transplant care are essential to optimizing patient outcomes. Emerging diagnostic and therapeutic innovations, including precision medicine, offer promising avenues to enhance survival and quality of life for patients undergoing lung transplantation.